ABSTRACT
INTRODUCTION
Efficient, high yield production of biologically useful proteins is of great utility for research and medical needs. Although there are many protein expression systems currently available, their products often have serious limitations of yield, purification, instability and toxicity. This report describes the novel T4 phage-derived protein expression, packaging and processing (PEPP) system that has notable advantages over other systems. The PEPP system gives not only high-yield production of intractable proteins, but stabilizes unstable proteins, processes proteins and targets them specifically to the capsid where they are retained intact for extended periods of time until needed. The PEPP system has generated applications that reveal insights into fundamental questions, such as the structure of viral-encapsidated DNA (8) and the requirements of protein targeting to phage capsids (7) . Additionally, the PEPP system provides a means of studying protein folding divorced from transcription and translation processes. When foreign proteins are packaged into phage and isolated, subsequent controlled, forced ejection through the phage tail tube can permit observation of the segregated refolding pathway (4) . The PEPP system also can serve as a model of protein interaction with condensed DNA, e.g., because foreign proteins can be packaged within the phage DNA condensate, PEPP can mimic the metaphase chromosome. Condensation and decondensation is an operative characteristic of DNA in both chromosomes and viral genomes and, consequently, has strong functional ramifications for transcriptional control. The extraordinarily dense state of DNA (ca. 520 mg/mL) achieved in the viral condensate is of fundamental significance to the control of DNA functions in all life forms.
Bacteriophage T4 contains a 170-kb genome, with associated internal proteins, including about 300 molecules of nonessential internal protein III (IPIII) (2) . Previous work in our laboratory has shown that IPIII can be used to introduce foreign proteins into the capsid by means of IPIII-fusions, e.g., IPIII T -β -globin and IPIII T -β -galactosidase (4) . We recently demonstrated that the Nterminal 10 amino acid sequence of IPIII is the minimal requirement for targeting foreign proteins into the T4 capsid, thus serving as a capsid targeting sequence (CTS) (7) . Many mature phage proteins, including IPIII, are derived by posttranslational cleavage of precursor proteins, where controlled, limited proteolysis by the viral scaffold protease P21 yields mature capsid proteins (2) . This feature of processing by P21, and targeting by the CTS, have both been incorporated into the PEPP system. Placement of a P21 site in a bridging sequence between the C-terminal end of the consensus CTS and the N-terminal start of a foreign protein permits proteolytic processing and liberates free, foreign protein within the capsid (7). Addition of both the CTS and the P21 cleavage site to a foreign protein is easily accomplished by standard polymerase chain reaction (PCR) techniques, and the resultant gene can be recombined into the T4 genome, giving a self-replicating phage that packages and processes a foreign protein to a copy number of about 200 molecules per phage.
This report presents an example of the use of the PEPP approach to produce a refractory protein, human immunodeficiency virus type 1 (HIV-1) protease, which is one of the prime targets in the development of a treatment for AIDS. HIV-1 protease possesses proteolytic activity that renders it toxic to bacterial host cells (3, 9, 10) . Also, the protease produced in E. coli expression systems has to be purified by difficult processes that generally involve extraction from insoluble inclusion bodies (6) . Production efficiency in E. coli is limited both by yield and by solubility of the protease in the bacterial cytoplasm, problems that are circumvented by encapsidation of protein into phage.
MATERIALS AND METHODS

Plasmids
The gene encoding HIV-1 protease was obtained from ATCC, Rockville, MD, USA (Accession No. 68352, plasmid clone of HIV-1 pol:protease, E. coli β -galactosidase [ β -gal] lacZ, designated p1+IQSau ) (1) . The green fluorescent protein (GFP) gene was a PCR product (8) obtained from pRAY1, a gift from Dr. Thomas E. Hughes, courtesy of Life Technologies (Gaithersburg, MD, USA). The 300-bp Eco RI-Pst I PR gene was cloned into vector p12-1 (8) and placed in-frame by inclusion of a BamHI-Eco RI linker (5 ′ -GGA TCC GAA TTC-3 ′ ), then the CTS wGFP:PR fusion was Hin dIII-excised and inserted into p247 (7) to create recombination vector p47-28, which was used to recombine CTS wGFP:PR into the T4 genome ( Figure 1 ). Strain BL21 carrying plasmid p47-28 (designated BL21[p47 -CTS wGFP:PR]) produces the 35-kDa fusion protein CTS wGFP:PR. The gene encoding the altered β -gal that contains HIV-1 protease cleavage site N-Val-Ser-Phe-Asn-Phe ∆ Pro-Gln-IleThr-Leu-C (1) was BamHI-excised from p1+IQSau , and the 4-kb fragment was cloned into pET11d to give the p β -gal ∆ p used to transform JM105. Strain
, which is cleaved from 115-kDa to an approximately 95-kDa product by active HIV-PR. JM105 carrying two plasmids, p47-28 and p β -gal ∆ p, which encode CTS wGFP:PR and β -gal ∆ p, respectively, is designated JM105[p47CTS -wGFP:PR+p β -gal ∆ p], and IPTG-induction gives both the 115 kDa intact protein and its 95-kDa cleavage product due to co-expression of both CTS wGFP:PR and β -gal ∆ p. Figure 1 4-6 h ). Lysis-inhibited bacteria are harvested by centrifugation at 4°C for 20 min at 6000 ×g . Pellets are resuspended with 10 U of DNase followed by methanol-extraction and incubation for 20 min at 30°C and four sequential centrifugations for 10 min at 6000 ×g . Supernatants are placed over continuous, preformed CsCl gradients and centrifuged to equilibrium for 12 h to give pure phage.
Recombinant Phage
Activity Assay
Activity of GFP:PR was assessed by appearance of the 95-kDa product from cleavage of the 115-kDa β -gal ∆ p on a Western immunoblot incubated with ß-gal antiserum. JM105[p47CTS wGFP:
were (i) grown in the medium described above to OD 600 values of 0.4, (ii)induced with 1 mM IPTG and (iii) aliquots were removed at various times. For mixture experiments, cell extracts were created by centrifugation of cells 10 min at 8000 × g , resuspension of cell pellets in 50 mM Tris-HCl, pH 7.0 buffer with 1 mM EDTA, addition of lysozyme to 1 mg/mL, incubation 15 min on ice, another centrifugation, resuspension in buffer to 1/100 of the original volume and three freeze-thaw cycles, after which extracts were incubated with ruptured phage or other extracts. Phage were ruptured by 7 cycles of freezing on dry ice followed by thawing in a 30°C water bath. Samples were then treated with 0.1% sodium dodecyl sulfate (SDS) sample buffer, heated at 95°C for 15 min and run over 8% SDSpolyacrylamide gels, followed by electrotransfer onto Immobilon ® (Millipore, Bedford, MA, USA) and Western blotting with β -gal antiserum. Blots were developed by the ECL ™ technique (Product No. RPN2109; Amersham Pharmacia Biotech, Piscataway, NJ, USA).
RESULTS AND DISCUSSION
According to the scheme depicted in Figure 1 , the gene encoding human HIV-1 protease was fused with GFP from jellyfish Aequorea victoriaand recombined into the T4 genome. GFP allowed rapid screening of positives by fluorescence. Inclusion of the N-terminal CTS enables targeting to the phage capsid and processing at the P21 cleavage site. After packaging into the capsid at the consensus sequence NLeu/Ile-X-Glu-w-Ala-C (7), protease P21 processes proteins at the N terminus as demonstrated by cleavage in several other constructions (7, 8) and constitutes another useful feature of the PEPP system that permits planned protein processing. The CTS is subsequently cleaved at the C terminus after the foreign protein is packaged, and the CTS is easily incorporated into a gene by standard PCR techniques.
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Vol. 25, No. 6 (1998) The 22-kDa band in lanes 4 and 9 is also seen in control pure GFP protein lanes 1 and 5 and is thought to be a GFP degradation product resulting from boiling and freezing during sample preparation.) (B) Western blot analysis of CTS wGFP:PR activity. Samples were run by 8% SDS-PAGE and blotted with β -gal antiserum. Fusion of the HIV-1 PR to GFP did not alter the spectrographic profile, since emission remained maximum at 506 nm in response to excitation at 442 nm (Figure 3 ). Similar to other packaged GFPfusion proteins (8) , GFP fused to PR and packaged within the capsid appears to retain the native GFP conformation and activity. The GFP moiety of the GFP:PR fusion protein provided a rapid means of quantitating the protein packaged within the capsid. Packaged GFP:PR was quantified by relative fluorescence intensity compared with a known amount of native GFP (Figure 3 ), indicating GFP:PR is present at approximately 200 molecules per phage particle. Quantitation by fluorescence emission was found to be comparable to measurement by densitometric scanning of Coomassie ® Blue-stained gels and Western blotting dilution series comparisons (8) . The amount of GFP:PR contained within the packaged T4 capsids is calculated according to the equation: (5 × 10 13 phage/mL) × (200 molecules per phage) ×(32 000 Da/molecule) ÷ (6.022 × 10 23 molecules/mole) = 0.00053 g/mL Because 28% of the final value is the PR molecule, the 2 mL-quantity of phage produced here yields 0.30 mg of PR. The CTS limits the amount of protein that can be targeted to the phage to a maximum theoretical yield of approximately 300-400 copies per particle (7, 8) .
The results of experiments to determine whether GFP:PR can cleave β -gal ∆ p are shown in the Western blot in Figure Figure 2B , lane 7, lower band) after a 60-min incubation, indicating protease activity. The PR moiety of GFP:PR therefore attains proteolytic activity in this fusion form. Although evidence of proteolytic activity is seen in the experiments here where PR is encumbered with GFP, conditions were not optimized, and activity was assessed only qualitatively for cleavage product by Western analysis. The specific activity for packaged GFP:PR under our assay conditions is roughly 2 nm/min per mg, about 100 times less than the native protease under equivalent conditions. To harvest the packaged phage protein contents, phage can be ruptured by 5-7 rapid freeze-thaw cycles, or ejection can be triggered by addition of dimyristic acid phosphatidyl glycerol (DMPG) (4). Rupturing capsids permits reclamation of intact packaged foreign proteins without unfolding of larger proteins during extrusion through the 4-nm diameter tail tube that occurs during ejection. Other work has demonstrated that small packaged, processed foreign proteins are active after injection into appropriate bacterial cell hosts and are active as they reside within the packaged phage, as shown with 29-kDa GFP and 15-kDa SN (8) . Packaged β -gal is inactive and only exhibits activity after injection into bacteria followed by refolding (4). Thus harvesting and restoration of activity must be tailored to the individual protein being produced.
The large amount of T4 progeny produced by infection of host bacteria combined with the stabilizing effect of T4 on foreign proteins (ordinarily subjected to host proteases) (5) and simple T4 purification procedures can give a relatively quick and high yield of packaged and processed protein. A theoretical scale-up to 1 L of phage with a titer of 10 13 phage/mL, where 200 molecules of a 75-kDa protein are packaged per phage, will give approximately 250 mg of processed foreign protein. Identification and purification are simplified by the presence of very few packaged phage proteins compared with the large number (thousands) of total E. coli proteins. The vast amounts of T4 progeny that can be produced and the ease of T4 purification render the final quantity of processed foreign protein produced to be quite dramatic.
Virtually any protein is amenable to the PEPP system; furthermore, in addition to its use in refractory protein production, the PEPP system has demonstrated useful applications towards resolving questions in areas such as protein targeting (7), DNA packaged structure (8) and protein folding (4). To summarize, features of the phage T4-derived PEPP system are described in Table 1 . 
INTRODUCTION
Site-directed mutagenesis (SDM) of DNA is now commonly performed by methods using the polymerase chain reaction (PCR) technique. One popular and highly efficient procedure is recombination PCR (RPCR), which uses two mutagenic and nonmutagenic oligonucleotide pairs to generate two overlapping fragments of the entire plasmid under study. Recovery of the mutant clone is achieved after in vivo recombination between these PCR products (3, 4) . Although successful application of RPCR to mutagenesis of a plasmid of 7.1 kb was reported (8) , in some circumstances, mutagenesis of inserts in larger plasmids (e.g., baculovirus transfer vectors >10 kb) would be desirable. However, this would require amplification of DNA target sequences of >5 kb and raises concerns over the introduction of spurious mutations due to the lack of proofreading activity associated with TaqDNA polymerase.
During our studies on the expression, in the baculovirus system of the glycoprotein (gp) of a wild-type (WT) rabies virus, we wished to examine the effect of altering particular structural motifs, especially N-glycosylation sites, of the protein. To facilitate production of several mutant versions of this protein, we investigated the feasibility of combining RPCR with the principles of long-distance PCR (1), in which efficient and accurate amplification is achieved using a mixture of thermostable DNA polymerases that combine high processivity and proofreading properties. This report investigates the feasibility of such an approach for SDM of large plasmids.
MATERIALS AND METHODS
Plasmid Construction
An expression cassette (RG) comprising the rabies gp open reading frame downstream of a ribosome binding site and bounded by BamHI sites was constructed by reverse transription (RT)-PCR of the G gene of street rabies virus [arctic fox strain (6); GenBank ® Accession No. U11754]. This cassette was cloned into the BamHI site of baculovirus transfer vectors pAcYM1 and pAcMP3, which use the polyhedrin and basic protein promoters, respectively, to generate the plasmids pAcYM-RG and pAcMP-RG (see Figure 1 ). Table 1 summarizes the primers used for clone characterization and mutagenesis at 3 sites within the G gene. Partially overlapping nonmutagenic PCR primers (BAC+/-) are directed to a site in the pUC portion of the transfer vector and generate PCR products with a 34-bp overlap. The mutagenic primer pairs were generally entirely complementary and generated PCR products overlapping by 28 bp (S3+/S3-), 34 bp (S1+/S1-, S1(a)+/S1-and S3(a)+/S3-) and 37 bp (S2+/S2-). For each trial, plasmid was digested separately with Sca I for use with primer BAC+ and SstII (pAcMP-RG) or EagI (pAcYM-RG) for use with primer BAC-. Digests were terminated by heating (65°C for 10 min), and DNA was diluted to 25 ng/ µ L with 0.1 ×TE buffer (1 mM Tris-HCl, pH 8.0, 0.1 mM EDTA). Using one mutagenic primer and one nonmutagenic primer, PCR was performed on each linearized plasmid by the Expand ™ Long Template PCR System according to the supplier's directions (Boehringer Mannheim Canada, Laval, QC, Canada). Reactions of 50 µ L contained 50 mM Tris-HCl, pH 9.2, 16 mM ammonium sulphate, 1.75 mM MgCl 2 , 0.35 mM each dNTP, 300 nM of each primer, 25 ng of plasmid template and 2.5 U of enzyme mixture ( Taqand PwoDNA polymerases). Thermal cycling was performed in a GeneAmp ® PCR System 9600 (PE Applied Biosystems, Foster City, CA, USA) as follows: 2-min denaturation at 93°C, 10 cycles of 93°C for 10 s, 65°C for 30 s, 68°C for 4 min, followed by 15 cycles of the same profile with a 20-s increment in extension time/cycle. PCR product yield was confirmed by agarose gel electrophoresis before recovery by phenol-extraction and ethanol-precipitation. Final dried pellets were dissolved in 10 µ L 0.1 × TE buffer.
Site-Directed Mutagenesis
PCR products (1 µ L) were transformed either together (for homologous 
Transformant Characterization
Transformants were grown in selective media for mini-scale plasmid preparation using Wizard ® Minipreps DNA Purification Systems (Promega, Madison, WI, USA). DNA sequencing was performed using fmol ® DNA Cycle Sequencing Systems (Promega) and 32 P-labeled primers directed to the rabies G gene.
Recombinant Baculovirus Generation and gp Expression
All transfer vector constructs were used in homologous recombination, performed with BaculoGold ® Linearized Baculovirus DNA (PharMingen, Mississauga, ONT, Canada), in Sf 9 cells grown in TNM medium supplemented with 10% fetal bovine serum (FBS) by standard methods (7) . Following a single round of plaque purification, DNA was prepared from smallscale baculovirus stocks as described previously (2), and recombinants were characterized by PCR (using primers BAC1-4) and sequencing.
For rabies gp expression, Hi-5 ( Trichoplusia ni ) cells, grown in Sf-900 II serum-free medium (SFM) (Life Technologies), were infected with recombinant baculovirus at a multiplicity of infection of 5. Tunicamycin (Sigma Chemical, St. Louis, MO, USA), where required, was added to growth medium at 5 µ g/mL. Cells were harvested after 3 days and resuspended in disruption buffer [5.7 M urea, 2.8% sodium dodecyl sulfate (SDS), 1.8 M 2-mercaptoethanol]. These crude protein samples were subjected to electrophoresis through 10% polyacrylamide-SDS gels and transferred to nitrocellulose membrane. After washing in blocking buffer [5% skim milk powder, Tris-buffered saline (TBS), pH 8.0, 0.3% Tween ® 20], the membrane was incubated with rabbit anti-rabies gp polyclonal antiserum for 2 h. Following three 5-min washes in TBS, the blot was incubated with goat anti-rabbit IgG alkaline phosphatase conjugate (Jackson Laboratories Bio/Can, Mississauga, ONT, Canada) for 2 h. After subsequent washing, protein bands were visualized by incubation with nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) substrate.
RESULTS
Mutations were directed to three sites within the RG cassette (see Figure  1 ): (i) S1, corresponding to amino acid (aa) 39 of mature gp, changes NXS to NXT and enhances N-glycosylation efficiency for the rabies ERA strain gp (5); (ii) S2 (aa 204/206), an additional N-linked glycosylation site, similar to that observed in other rabies strains, is incorporated; and (iii) S3 (aa 73), a ser to asn substitution, which does not alter N-glycosylation, is made. Table 2 summarizes the results of six separate trials in which the production of four distinct mutant clones was evaluated. For each trial, plasmid DNA was prepared from 12 or more transformants generated by homologous recombination and analyzed by BamHI digestion; all clones, with the exception of one from trial 1b, harbored a plasmid with restriction patterns consistent with the parental vector. Sequencing a fraction of these clones indicated that mutation rates approached 100% in most cases (Table 2) . In some trials, primers of different lengths were assessed for their mutagenesis efficiency. All primers generated the desired mutants with high efficiency except for the combination tested in experiment 4a. Replacement of the S3+ primer with S3(a)+ (having 6 additional bases at the 5 ′ end) in trial 4b apparently improved mutant recovery, perhaps by facilitating recombination due to the longer overlap (34 bp vs. 28 bp) between PCR products at the mutagenic site. The proofreading ability of the DNA polymerase mixture used will necessitate using primers retaining a certain minimal length 3 ′ terminal to the mutagenic base(s), thereby avoiding inadvertent repair of the mismatch; the shortest such sequence used here [9 bp in S1(a)+] was clearly sufficient for this purpose, and even shorter stretches might be successfully used.
To further evaluate sequence fidelity, a 250-300-base segment was sequenced for 48 mutant plasmids. In addition, the entire RG was sequenced for one clone of each of the four mutant genes generated. Of a total of 16 200 bases sequenced, only one inadvertent base change relative to the parental G gene sequence was found; a C to T substitution that would cause a conservative coding change (ala to val) close to S1. Plasmids pAcMP-RG and pAcYM-RG (WT G gene) and plasmids bearing the G gene mutants (pAcMP-RG-S1, pAcMP-RG-S2, pAcMP-RG-S1,2 and pAcYM-RG-S3) were used to generate recombinant baculoviruses (BAcMP-RG, BAcYM-RG etc). Rabies gp production by these recombinants was evaluated by Western blot (Figure 2 ). All cells infected with recombinant baculoviruses produced a protein of 58-65 kDa that cross-reacted with rabbit antirabies gp polyclonal anti-serum. This product was absent in control cells and cells infected with WT baculovirus. Treatment of infected cultures with tunicamycin, an inhibitor of N-linked glycosylation, reduced the size of all products to 58 kDa (data not shown).
DISCUSSION
This report details the feasibility of using principles of long-distance PCR coupled with RPCR for SDM of large plasmids. We have demonstrated the speed (similar to RPCR) and accuracy (<1 error per 16 000 bases) of this method by producing and characterizing four rabies G gene mutants. Expression of these mutated genes in the baculovirus/insect cell system yields proteins differing in size as predicted by the differential presence of N-glycosylation sites. The ability of tunicamycin to reduce all products to a common size supports the role of Nglycosylation in determining these size differences. This SDM method is attractive for any large plasmid, but given a The reverse orientation of the pUC fragment in pAcYM1, compared to pAcMP3 relative to the inserted gene (see Figure 1) , requires that opposite pairings of primers be used for amplification. b This experiment was performed on plasmid already mutated at S1 (Experiment No. 1). Table 2 . Summary of SDM of pAcMP-RG1 and pAcYM-RG1 a the popularity and versatility of the insect/baculovirus protein expression system, the application described in this report is particularly relevant. By avoiding time-consuming subcloning of mutant genes into baculovirus transfer vectors without compromising the fidelity of the inserts themselves, combined with current rapid methods for generating recombinant baculoviruses through homologous recombination, this mutagenesis method will greatly facilitate structure-function studies in this expression system.
